These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33887388)

  • 1. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL; Lee BJ; Tran TTD
    Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A; Ogawa H; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.
    Patil H; Tiwari RV; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):20-42. PubMed ID: 26159653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Performance of Innovative Polyelectrolyte Matrices for Hot Melt Extrusion of Amorphous Drug Systems.
    Ditzinger F; Wieland R; Statelova M; Vertzoni M; Holm R; Kuentz M
    Mol Pharm; 2020 Aug; 17(8):3053-3061. PubMed ID: 32589437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of rheology in formulation and process design of hot melt extruded amorphous solid dispersions.
    Badruddoza AZM; Moseson DE; Lee HG; Esteghamatian A; Thipsay P
    Int J Pharm; 2024 Oct; 664():124651. PubMed ID: 39218326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot-Melt Extrusion: a Roadmap for Product Development.
    Simões MF; Pinto RMA; Simões S
    AAPS PharmSciTech; 2021 Jun; 22(5):184. PubMed ID: 34142250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion.
    Han J; Tang M; Yang Y; Sun W; Yue Z; Zhang Y; Zhu Y; Liu X; Wang J
    Int J Pharm; 2023 Nov; 646():123490. PubMed ID: 37805146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application research of hot-melt extrusion in preparation of solid dispersion].
    Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
    Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
    Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot-melt extrusion--basic principles and pharmaceutical applications.
    Lang B; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1133-55. PubMed ID: 24520867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
    Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
    Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century.
    Tiwari RV; Patil H; Repka MA
    Expert Opin Drug Deliv; 2016; 13(3):451-64. PubMed ID: 26886062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
    Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
    AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
    Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.